Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
DeepSeek’s latest models, created by a small company with limited resources, are already beating many of the leading AI ...
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
The protocol aims to rival OpenAI founder Sam Altman's Worldcoin project, which is built around scanning users' irises.
DeepSeek R1, the surprisingly efficient and powerful Chinese AI model, has taken the technology industry by storm and is ...